The news story you are looking for has expired. A more recent related article is displayed below.

Sponsored Links

Major Pharmaceutical Company Signs Contract with BTS Group

BTS Group AB, a provider of customized business simulations and other discovery-based learning solutions, announced it has been selected for an initial MUSD 2.8 contract, of which MUSD 1.5 are licenses, to deliver the first phase of a broad curriculum of business leadership development programs at a global pharmaceuticals corporation.

The curriculum's purpose is to build business leadership and execution capability in over 9,000 frontline managers worldwide.

The project provides a range of learning components, including:

- initial assessments

- online communities

- online coursework

- immersive scenario and business simulations

All of the above is intended to be a continuum of learning rather than a single event. The program incorporates BTS' Advantage Way process which engages senior leaders in a way that creates a "line of sight" from each learner to their organization's goals and strategic priorities.

The BTS methodology begins with mapping the impact of the project, which closely aligns the learning initiative to corporate goals and the process culminates with built-in mechanisms that capture ROI and success cases for replication across the firm.

BTS and the client will deliver the curriculum in 9-10 different languages to thousands of employees, increasing the relevancy and immediacy of the content. BTS global reach secures the ability to deliver localized sessions on demand. The client will also broadly implement a train-the-trainer process to engage leaders in various markets in the delivery of the sessions.

"This program accelerates the time to adoption of new behaviors established by the company's senior leadership," said Rommin Adl, executive VP, BTS. "The integration of the BTS' Advantage Way Process ensures leader engagement on delivering business results."

"We are proud to be working with this global leader in the pharmaceutical Industry on this initiative with a global rollout and an extremely rapid implementation phase - we believe our process and high impact learning methodologies represent the future of effective learning," said Henrik Ekelund, President and CEO of BTS Group AB.

BTS is a public company listed on the Swedish Stock Exchange.

((Comments on this story may be sent to newsdesk@closeupmedia.com))

Copyright (C) 2009 Close-Up Media. All rights reserved

News Provided by COMTEX


Related terms: adoption, business, ceo, contract, corporate, executive, licenses, online, pharmaceuticals, president

Related Articles

BTS signs a three year partnership with a global leading professional service provider worth in
Oct 28, 2009
...Sweden and San Francisco, USA - BTS Group AB (publ), the world's leading...Henrik Ekelund, President and CEO of BTS Group AB. "This is strong evidence of our...Investor and Corporate Communications BTS Group AB Phone +46-8-5870 7002 Mobile...

Transportation news: BTS says surface trade with Mexico and Canada down 24.9 percent in August
Oct 29, 2009
Click Here Transportation news: BTS says surface trade with Mexico and Canada...s Bureau of Transportation Statistics (BTS). Unlike the previous seven months...year decline of more than 27 percent. The BTS said the value of U.S. surface transportation...

Swine Flu Injects Some Life Into Injection Molders
Oct 17, 2009
...called Delaney Manufacturing got a rush order for up to 50,000 polystyrene trays used to ship vaccine from a major pharmaceutical company. Delaney was first contacted in July, and began production in mid-October. The first shipment is...

Freight demand shows more signs of pickup
Oct 15, 2009
...Department of Transportation's Bureau of Transportation Statistics (BTS) reported in September that its Freight Transportation Services...Department of Transportation's Bureau of Transportation Statistics (BTS) reported in September that its Freight Transportation Services...